Categories: BioTechBuildingDataHardwareHealthTechIndustryMedtechNetworksPersonalResearch
Sinaptica Therapeutics™ has developed a breakthrough personalized closed-loop neuromodulation therapy for Alzheimer’s Disease that works by enhancing neuroplasticity via neurostimulation of key brain networks involved in memory.
Investors 4
Mentions in press and media 1
| Date | Title | Description |
| 29.07.2026 | Healing Without Drugs: A Promising Future for Alzheimer’s Patients | Chuck Papageorgiou, CEO, NeuroEM Therapeutics
Of the medical diagnoses that cause anxiety, sorrow, and despair for patients and their loved ones, Alzheimer’s is near the top of the list. An incurable condition that slowly robs people of mem... |
Reviews 0
